Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Symptomate is a commercial digital health product and brand in symptom assessment and care navigation, positioned as a self-service symptom checker made by doctors. It is part of Infermedica, a Poland-founded healthcare AI company that develops symptom checker, triage, intake, and API-based decision-support tools for patients, providers, insurers, and other healthcare organizations. Symptomate is used by consumers directly through web and mobile experiences and is also offered to businesses as a white-label or licensable symptom assessment solution. The product uses an AI-based inference engine and a medically curated knowledge base to analyze symptoms, suggest likely conditions, and recommend next steps or level of care. In the EU, Infermedica states its platform modules are certified medical devices under MDR, supporting its positioning as a clinically oriented healthcare technology offering rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symptomate.